[{"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-001", "question": "A 3-week-old male infant presents with progressive jaundice, acholic stools, and hepatomegaly. Laboratory studies reveal total bilirubin 12.4 mg/dL (direct 9.8 mg/dL), GGT 890 U/L, and ALT 156 U/L. Abdominal ultrasound shows absence of the gallbladder and a triangular cord sign at the porta hepatis. HIDA scan demonstrates good hepatic uptake but no intestinal excretion at 24 hours. Intraoperative cholangiogram confirms biliary atresia. The Kasai portoenterostomy is performed at 28 days of life. Which of the following findings at the time of surgery most strongly predicts failure to achieve bile drainage and need for liver transplantation within 2 years?", "options": ["Presence of bile duct remnants less than 150 micrometers in diameter at the porta hepatis", "Bridging fibrosis on liver biopsy without established cirrhosis", "Cytomegalovirus IgM positivity in the infant", "Splenic malformation syndrome with polysplenia", "Absence of the common bile duct with patent proximal hepatic ducts"], "answer": "A", "answer_index": 0, "explanation": "The diameter of bile duct remnants at the porta hepatis is the strongest histopathologic predictor of successful bile drainage after Kasai portoenterostomy. Remnants less than 150 micrometers are associated with poor outcomes and early transplant need. Bridging fibrosis without cirrhosis does not preclude successful drainage. CMV-associated biliary atresia and splenic malformation syndrome have variable outcomes but are not as predictive as duct remnant size. Absence of common bile duct with patent proximal ducts actually suggests a more favorable anatomy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Classic biliary atresia (direct hyperbilirubinemia, acholic stools, high GGT, triangular cord sign, no excretion on HIDA) with confirmed diagnosis and Kasai done at 28 days. The question asks which intraoperative finding best predicts failure of bile drainage and early need for liver transplant. Option A describes very small bile duct remnants (<150 μm) at the porta hepatis, a well-established negative prognostic factor because inadequate ductal caliber limits postoperative bile flow. Bridging fibrosis (B) indicates disease severity but does not independently predict failure once cirrhosis is absent. CMV IgM positivity (C) and splenic malformation syndrome (D) are associated with variable, but not consistently the strongest, prognostic impact compared with duct size. Option E (absence of common bile duct with patent proximal ducts) tends to correspond to a more favorable anatomic subtype for Kasai outcome. No internal contradictions or underspecification are apparent; choices are clearly differentiable and reflect current understanding of prognostic factors in biliary atresia.\\nMinimal fix: Add a phrase like “Based on current outcome studies…” to reinforce the prognostic focus, but not strictly necessary.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Classic biliary atresia (direct hyperbilirubinemia, acholic stools, high GGT, triangular cord sign, no excretion on HIDA) with confirmed diagnosis and Kasai done at 28 days. The question asks which intraoperative finding best predicts failure of bile drainage and early need for liver transplant. Option A describes very small bile duct remnants (<150 μm) at the porta hepatis, a well-established negative prognostic factor because inadequate ductal caliber limits postoperative bile flow. Bridging fibrosis (B) indicates disease severity but does not independently predict failure once cirrhosis is absent. CMV IgM positivity (C) and splenic malformation syndrome (D) are associated with variable, but not consistently the strongest, prognostic impact compared with duct size. Option E (absence of common bile duct with patent proximal ducts) tends to correspond to a more favorable anatomic subtype for Kasai outcome. No internal contradictions or underspecification are apparent; choices are clearly differentiable and reflect current understanding of prognostic factors in biliary atresia.\nMinimal fix: Add a phrase like “Based on current outcome studies…” to reinforce the prognostic focus, but not strictly necessary.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-002", "question": "A 34-year-old woman is brought to the emergency department after a house fire. She was found unconscious in a closed room. On arrival, she is obtunded with GCS 8. Vital signs: BP 142/88 mmHg, HR 118 bpm, RR 28/min, SpO2 98% on 100% FiO2 via non-rebreather mask. Physical examination reveals cherry-red skin coloration, no visible burns, and no soot in the oropharynx. Arterial blood gas on 100% oxygen shows pH 7.18, PaCO2 28 mmHg, PaO2 487 mmHg, lactate 14 mmol/L. Carboxyhemoglobin level is 8%. Co-oximetry reveals an additional abnormal hemoglobin species at 18%. Which of the following is the most appropriate next step in management?", "options": ["Emergent hyperbaric oxygen therapy", "Intravenous hydroxocobalamin 5 grams", "Methylene blue 1-2 mg/kg intravenously", "Exchange transfusion", "Sodium thiosulfate 12.5 grams intravenously"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation with severe lactic acidosis, obtundation, relatively low carboxyhemoglobin but an additional abnormal hemoglobin species (18% methemoglobin-like reading which actually represents cyanohemoglobin on co-oximetry) in a fire victim strongly suggests cyanide toxicity from combustion of synthetic materials. Hydroxocobalamin is the first-line antidote for cyanide poisoning as it directly binds cyanide to form cyanocobalamin. Hyperbaric oxygen addresses CO toxicity but CO level is only 8%. Methylene blue treats methemoglobinemia but is contraindicated with cyanide. Sodium thiosulfate is slower acting and used as adjunct therapy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: House fire in closed space; found unconscious; severe lactic acidosis (lactate 14) with high anion gap metabolic acidosis (pH 7.18, low PaCO2 from compensation); cherry-red skin; very high PaO2 on 100% FiO2; relatively low carboxyhemoglobin (8%) plus an additional abnormal hemoglobin species at 18% on co-oximetry; no significant airway burn signs. This constellation strongly suggests smoke inhalation with cyanide toxicity from burning synthetic materials, rather than primarily carbon monoxide poisoning. Hydroxocobalamin is the first-line, rapidly acting cyanide antidote and is thus the most appropriate next step.\\nOption review: A (hyperbaric O2) is for significant CO poisoning, which is not supported by a COHb of 8%. C (methylene blue) treats methemoglobinemia, not cyanide, and is not indicated here. D (exchange transfusion) is not standard for either cyanide or this level of CO exposure. E (sodium thiosulfate) is slower, adjunctive for cyanide, not the primary emergent choice.\\nMain medical accuracy issues: Minor—co-oximetry reading attribution is somewhat simplified but educationally acceptable.\\nMinimal fix: Clarify in the stem that co-oximetry flags “dyshemoglobin species consistent with cyanide exposure” to avoid interpretive ambiguity.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: House fire in closed space; found unconscious; severe lactic acidosis (lactate 14) with high anion gap metabolic acidosis (pH 7.18, low PaCO2 from compensation); cherry-red skin; very high PaO2 on 100% FiO2; relatively low carboxyhemoglobin (8%) plus an additional abnormal hemoglobin species at 18% on co-oximetry; no significant airway burn signs. This constellation strongly suggests smoke inhalation with cyanide toxicity from burning synthetic materials, rather than primarily carbon monoxide poisoning. Hydroxocobalamin is the first-line, rapidly acting cyanide antidote and is thus the most appropriate next step.\nOption review: A (hyperbaric O2) is for significant CO poisoning, which is not supported by a COHb of 8%. C (methylene blue) treats methemoglobinemia, not cyanide, and is not indicated here. D (exchange transfusion) is not standard for either cyanide or this level of CO exposure. E (sodium thiosulfate) is slower, adjunctive for cyanide, not the primary emergent choice.\nMain medical accuracy issues: Minor—co-oximetry reading attribution is somewhat simplified but educationally acceptable.\nMinimal fix: Clarify in the stem that co-oximetry flags “dyshemoglobin species consistent with cyanide exposure” to avoid interpretive ambiguity.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-003", "question": "A 58-year-old man with a history of chronic alcohol use disorder is undergoing emergency laparotomy for perforated duodenal ulcer. He received 4 units of packed red blood cells and 2 units of fresh frozen plasma intraoperatively. Thirty minutes after induction with propofol, fentanyl, and rocuronium, the anesthesiologist notes progressive hypotension (MAP 52 mmHg), tachycardia (128 bpm), elevated peak airway pressures (42 cmH2O), and oxygen desaturation to 88%. Central venous pressure has increased from 6 to 18 mmHg. There is no urticaria or angioedema. Bronchospasm is noted on auscultation. Serum tryptase drawn at this time returns elevated at 48 ng/mL (normal <11.4). Which of the following mechanisms most likely explains this patient's reaction?", "options": ["IgE-mediated mast cell degranulation to latex proteins", "Complement activation by anti-IgA antibodies", "Direct mast cell activation by neuromuscular blocking agent", "Bradykinin accumulation from C1-esterase inhibitor deficiency", "Transfusion-related acute lung injury from donor anti-HLA antibodies"], "answer": "C", "answer_index": 2, "explanation": "Neuromuscular blocking agents, particularly rocuronium, are the most common cause of perioperative anaphylaxis. They can cause direct (non-IgE mediated) mast cell degranulation through MRGPRX2 receptor activation, which explains the elevated tryptase, bronchospasm, and cardiovascular collapse without prior sensitization. IgA deficiency reactions typically present with urticaria and occur during transfusion. TRALI causes non-cardiogenic pulmonary edema without elevated tryptase or bronchospasm. Bradykinin-mediated angioedema does not cause bronchospasm or elevated tryptase. Latex allergy is less common and typically requires mucosal contact.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Emergency laparotomy under general anesthesia with propofol, fentanyl, rocuronium; onset 30 minutes after induction; progressive hypotension, tachycardia, high peak airway pressures, bronchospasm, hypoxemia; elevated CVP; no urticaria/angioedema; markedly elevated serum tryptase. These findings are classic for perioperative anaphylaxis with mast cell degranulation. Among common intraoperative triggers, neuromuscular blocking agents (especially rocuronium) are most frequent, and they can cause non–IgE-mediated mast cell activation via MRGPRX2.\\nOption analysis: A (IgE to latex) is less likely: latex reactions generally require prior sensitization and exposure (e.g., mucosal/skin contact, usually later in case) and are IgE-mediated rather than “direct activation.” B (anti-IgA) fits transfusion reaction with urticaria, hypotension; but stem emphasizes bronchospasm, elevated tryptase, and no rash, making it less likely. D (bradykinin/C1-INH) causes angioedema without bronchospasm or elevated tryptase. E (TRALI) causes noncardiogenic pulmonary edema and hypoxemia without increased tryptase or bronchospasm, and typically normal CVP. Thus C is uniquely best and medically accurate.\\nMinimal fix: Clarify timing of rocuronium administration (e.g., “immediately before induction”) to strengthen temporal association with reaction, though the item is already discriminating.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Emergency laparotomy under general anesthesia with propofol, fentanyl, rocuronium; onset 30 minutes after induction; progressive hypotension, tachycardia, high peak airway pressures, bronchospasm, hypoxemia; elevated CVP; no urticaria/angioedema; markedly elevated serum tryptase. These findings are classic for perioperative anaphylaxis with mast cell degranulation. Among common intraoperative triggers, neuromuscular blocking agents (especially rocuronium) are most frequent, and they can cause non–IgE-mediated mast cell activation via MRGPRX2.\nOption analysis: A (IgE to latex) is less likely: latex reactions generally require prior sensitization and exposure (e.g., mucosal/skin contact, usually later in case) and are IgE-mediated rather than “direct activation.” B (anti-IgA) fits transfusion reaction with urticaria, hypotension; but stem emphasizes bronchospasm, elevated tryptase, and no rash, making it less likely. D (bradykinin/C1-INH) causes angioedema without bronchospasm or elevated tryptase. E (TRALI) causes noncardiogenic pulmonary edema and hypoxemia without increased tryptase or bronchospasm, and typically normal CVP. Thus C is uniquely best and medically accurate.\nMinimal fix: Clarify timing of rocuronium administration (e.g., “immediately before induction”) to strengthen temporal association with reaction, though the item is already discriminating.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-004", "question": "A 72-year-old woman with severe aortic stenosis (valve area 0.6 cm², mean gradient 58 mmHg) and preserved ejection fraction is scheduled for transcatheter aortic valve replacement. During the procedure under general anesthesia, rapid ventricular pacing at 180 bpm is initiated for valve deployment. Immediately after pacing is terminated, the arterial line shows a pressure of 45/30 mmHg with a heart rate of 42 bpm. TEE reveals severe paravalvular regurgitation and a pericardial effusion of 1.8 cm with right atrial collapse. Which of the following is the most appropriate immediate intervention?", "options": ["Initiate cardiopulmonary bypass via femoral cannulation", "Administer atropine 1 mg and epinephrine 100 mcg", "Perform emergent pericardiocentesis via subxiphoid approach", "Deploy a second transcatheter valve within the first valve", "Initiate peripheral venoarterial extracorporeal membrane oxygenation"], "answer": "C", "answer_index": 2, "explanation": "The clinical picture demonstrates cardiac tamponade (pericardial effusion with right atrial collapse and profound hypotension) likely from annular rupture or wire perforation during TAVR. Emergent pericardiocentesis is the immediate life-saving intervention to relieve tamponade physiology. While VA-ECMO or cardiopulmonary bypass may ultimately be needed, pericardiocentesis can be performed immediately and may stabilize the patient. Pharmacologic support alone will not address the mechanical problem. Deploying a second valve does not address the tamponade and may worsen annular injury.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Post-TAVR, under general anesthesia, patient develops profound hypotension (45/30 mmHg) and bradycardia, with TEE showing a large pericardial effusion (1.8 cm) and right atrial collapse—classic hemodynamically significant cardiac tamponade. Severe paravalvular regurgitation is also noted, but the immediately life‑threatening, clearly reversible lesion is tamponade.\\nRationale: In the setting of acute tamponade during a cath/TAVR procedure, immediate pericardial decompression is the priority. In this context, emergent pericardiocentesis (Option C) is the most direct, rapidly achievable, life-saving maneuver. Pharmacologic therapy (B) will not relieve tamponade. Initiating CPB (A) or VA-ECMO (E) may be reasonable adjuncts if available, but are slower, more logistically complex, and not the first immediate step when the diagnosis of tamponade is clear and image-guided drainage is feasible. Deploying a second valve (D) targets the regurgitation, not the tamponade, and could worsen an annular injury.\\nMain medical accuracy issues: None significant; the pathophysiology and priority of emergent pericardial decompression are correctly emphasized.\\nMinimal fix: Option C could specify “TEE-guided pericardiocentesis” to reflect procedural reality in a TAVR lab but is not required for clarity.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Post-TAVR, under general anesthesia, patient develops profound hypotension (45/30 mmHg) and bradycardia, with TEE showing a large pericardial effusion (1.8 cm) and right atrial collapse—classic hemodynamically significant cardiac tamponade. Severe paravalvular regurgitation is also noted, but the immediately life‑threatening, clearly reversible lesion is tamponade.\nRationale: In the setting of acute tamponade during a cath/TAVR procedure, immediate pericardial decompression is the priority. In this context, emergent pericardiocentesis (Option C) is the most direct, rapidly achievable, life-saving maneuver. Pharmacologic therapy (B) will not relieve tamponade. Initiating CPB (A) or VA-ECMO (E) may be reasonable adjuncts if available, but are slower, more logistically complex, and not the first immediate step when the diagnosis of tamponade is clear and image-guided drainage is feasible. Deploying a second valve (D) targets the regurgitation, not the tamponade, and could worsen an annular injury.\nMain medical accuracy issues: None significant; the pathophysiology and priority of emergent pericardial decompression are correctly emphasized.\nMinimal fix: Option C could specify “TEE-guided pericardiocentesis” to reflect procedural reality in a TAVR lab but is not required for clarity.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-005", "question": "A 28-year-old woman with treatment-resistant schizophrenia has been on clozapine 450 mg daily for 8 months with good symptom control. She presents with fever (39.2°C), sore throat, and malaise for 2 days. Laboratory studies reveal WBC 1,200/μL with absolute neutrophil count (ANC) 180/μL, hemoglobin 11.2 g/dL, and platelets 198,000/μL. Clozapine is immediately discontinued. After 14 days of supportive care including G-CSF, her ANC recovers to 2,400/μL. Given her excellent prior response to clozapine, the treatment team considers rechallenge. Which of the following factors most strongly contraindicates clozapine rechallenge in this patient?", "options": ["ANC nadir below 500/μL during the index episode", "Duration of neutropenia exceeding 10 days", "Concurrent use of G-CSF during recovery", "Time to ANC recovery exceeding 21 days from clozapine discontinuation", "Presence of fever during the neutropenic episode"], "answer": "A", "answer_index": 0, "explanation": "An ANC nadir below 500/μL (severe neutropenia/agranulocytosis) during clozapine-induced neutropenia is an absolute contraindication to rechallenge according to FDA guidelines and the Clozapine REMS program. Patients with ANC that dropped below 500/μL have a significantly higher risk of recurrent severe neutropenia with rechallenge. Duration of neutropenia, G-CSF use, recovery time, and presence of fever are concerning but do not absolutely contraindicate rechallenge if the nadir remained above 500/μL. The severity of the nadir is the critical determinant.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Clozapine use; severe neutropenia with ANC 180/μL (well below 500/μL); fever and sore throat; G-CSF use; ANC recovery to 2,400/μL in 14 days; team considering rechallenge and asking which factor most strongly contraindicates clozapine rechallenge. The critical regulatory/consensus point is that clozapine-induced severe neutropenia/agranulocytosis (ANC <500/μL) is a formal contraindication to rechallenge per FDA labeling/REMS; this focuses on the nadir value, not duration, presence of fever, or need for G-CSF.\\nOther options (B–E) may increase concern or influence risk–benefit discussions but are not defined as absolute or primary contraindications when nadir remains ≥500/μL. Thus, A is uniquely correct and matches the key.\\nNo internal contradictions or underspecification are present; the question clearly seeks the single most decisive regulatory/clinical barrier.\\nMedical accuracy: The description of ANC thresholds and the role of nadir severity in rechallenge decisions is consistent with standard clozapine monitoring guidance and REMS principles.\\nMinimal fix: Add “per FDA labeling and Clozapine REMS criteria” to the stem or explanation to explicitly ground the standard being tested.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Clozapine use; severe neutropenia with ANC 180/μL (well below 500/μL); fever and sore throat; G-CSF use; ANC recovery to 2,400/μL in 14 days; team considering rechallenge and asking which factor most strongly contraindicates clozapine rechallenge. The critical regulatory/consensus point is that clozapine-induced severe neutropenia/agranulocytosis (ANC <500/μL) is a formal contraindication to rechallenge per FDA labeling/REMS; this focuses on the nadir value, not duration, presence of fever, or need for G-CSF.\nOther options (B–E) may increase concern or influence risk–benefit discussions but are not defined as absolute or primary contraindications when nadir remains ≥500/μL. Thus, A is uniquely correct and matches the key.\nNo internal contradictions or underspecification are present; the question clearly seeks the single most decisive regulatory/clinical barrier.\nMedical accuracy: The description of ANC thresholds and the role of nadir severity in rechallenge decisions is consistent with standard clozapine monitoring guidance and REMS principles.\nMinimal fix: Add “per FDA labeling and Clozapine REMS criteria” to the stem or explanation to explicitly ground the standard being tested.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-006", "question": "A 45-year-old man with bipolar I disorder, currently euthymic on lithium monotherapy (level 0.9 mEq/L), develops new-onset nephrotic syndrome. Renal biopsy reveals minimal change disease. His nephrologist initiates prednisone 60 mg daily. Two weeks later, he presents with decreased need for sleep, pressured speech, grandiosity, and impulsive spending. Lithium level is 0.7 mEq/L. Which of the following is the most appropriate next step in management?", "options": ["Increase lithium dose to achieve level of 1.2 mEq/L", "Add valproic acid 500 mg twice daily", "Add olanzapine 10 mg at bedtime", "Discontinue prednisone and switch to cyclosporine", "Add lamotrigine 25 mg daily with gradual titration"], "answer": "C", "answer_index": 2, "explanation": "This patient has developed corticosteroid-induced mania, a well-recognized complication of high-dose glucocorticoid therapy. The most appropriate acute intervention is adding an atypical antipsychotic such as olanzapine, which has rapid antimanic efficacy and is FDA-approved for acute mania. Increasing lithium is problematic given nephrotic syndrome and potential nephrotoxicity. Valproic acid has hepatic and hematologic concerns with concurrent steroid use. Abruptly discontinuing prednisone could cause nephrotic syndrome relapse and adrenal insufficiency. Lamotrigine has no acute antimanic efficacy and requires slow titration.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Known bipolar I disorder, euthymic on therapeutic lithium; new high-dose prednisone for minimal change disease; onset within 2 weeks of classic manic symptoms (decreased need for sleep, pressured speech, grandiosity, impulsive spending); lithium level slightly lower but still therapeutic range for maintenance; recent glucocorticoid exposure strongly implicates steroid-induced mania on background bipolar vulnerability.\\nEvaluation of options: A) Raising lithium to 1.2 mEq/L increases renal risk in a patient with nephrotic syndrome and MCD; also lithium level is already reasonable and onset temporally linked to steroids. B) Valproate is an evidence-based mood stabilizer for acute mania but carries interaction and toxicity concerns; in a board-style \\\"single best\\\" context, an atypical antipsychotic is preferred for fastest antimanic effect. C) Olanzapine has rapid-onset antimanic efficacy and is standard for acute mania; no direct renal toxicity, fits best. D) Abruptly switching off prednisone in MCD can cause relapse and risks adrenal suppression; not first-line psychiatric management. E) Lamotrigine does not treat acute mania and requires slow titration.\\nMain medical issue: Minor—valproate is also reasonable but antipsychotic is more clearly first-line here.\\nMinimal fix: Clarify in stem that nephrologist prefers to continue high-dose steroids due to severe disease, making psychiatric pharmacologic management the focus.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Known bipolar I disorder, euthymic on therapeutic lithium; new high-dose prednisone for minimal change disease; onset within 2 weeks of classic manic symptoms (decreased need for sleep, pressured speech, grandiosity, impulsive spending); lithium level slightly lower but still therapeutic range for maintenance; recent glucocorticoid exposure strongly implicates steroid-induced mania on background bipolar vulnerability.\nEvaluation of options: A) Raising lithium to 1.2 mEq/L increases renal risk in a patient with nephrotic syndrome and MCD; also lithium level is already reasonable and onset temporally linked to steroids. B) Valproate is an evidence-based mood stabilizer for acute mania but carries interaction and toxicity concerns; in a board-style \"single best\" context, an atypical antipsychotic is preferred for fastest antimanic effect. C) Olanzapine has rapid-onset antimanic efficacy and is standard for acute mania; no direct renal toxicity, fits best. D) Abruptly switching off prednisone in MCD can cause relapse and risks adrenal suppression; not first-line psychiatric management. E) Lamotrigine does not treat acute mania and requires slow titration.\nMain medical issue: Minor—valproate is also reasonable but antipsychotic is more clearly first-line here.\nMinimal fix: Clarify in stem that nephrologist prefers to continue high-dose steroids due to severe disease, making psychiatric pharmacologic management the focus.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-007", "question": "A 32-year-old woman is brought to the psychiatric emergency department by police after being found wandering naked in a shopping mall, speaking in rhymes, and claiming to be receiving messages from television broadcasts. She has no psychiatric history. Toxicology screen is negative. Physical examination reveals a fine resting tremor, tachycardia (112 bpm), and lid lag. TSH is <0.01 mIU/L, free T4 is 6.8 ng/dL (normal 0.8-1.8), and free T3 is 18.2 pg/mL (normal 2.3-4.2). After initial stabilization with propranolol and methimazole, her psychotic symptoms persist at day 10 despite normalized heart rate. Which of the following antipsychotic medications carries the highest risk of worsening her underlying medical condition?", "options": ["Haloperidol", "Risperidone", "Quetiapine", "Aripiprazole", "Ziprasidone"], "answer": "C", "answer_index": 2, "explanation": "This patient has thyrotoxicosis-induced psychosis (thyroid storm with neuropsychiatric manifestations). Quetiapine has significant anticholinergic properties that can impair heat dissipation and worsen hyperthermia, which is particularly dangerous in thyroid storm where temperature dysregulation is already compromised. Additionally, quetiapine's alpha-adrenergic blockade can cause orthostatic hypotension, complicating the hemodynamic instability of thyrotoxicosis. Haloperidol, while having some risk of hyperthermia, has less anticholinergic activity. Risperidone, aripiprazole, and ziprasidone have minimal anticholinergic effects.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible), with elements of U.\\nVerdict on keyed answer: Not uniquely determinable; C is not clearly superior to A.\\nKey stem clues: Acute thyrotoxicosis with psychosis; treated with propranolol and methimazole; concern is choosing an antipsychotic that will not worsen thyrotoxicosis-related hyperthermia/hemodynamics. The explanation claims quetiapine’s anticholinergic and α-blocking properties make it most risky.\\nMain logical issues: The question asks which antipsychotic most worsens the underlying medical condition (thyrotoxicosis/thyroid storm). Standard board-relevant concern would more strongly implicate haloperidol: risk of neuroleptic malignant syndrome, dopamine blockade potentially interfering with thermoregulation, and known use of high-potency typicals in agitated medically ill patients with caution regarding hyperthermia and QT. Quetiapine’s anticholinergic burden is modest and often considered among the more tolerable atypicals; it is not classically singled out as the worst for hyperthermia in thyrotoxicosis. The item does not provide data on each drug’s relative anticholinergic effect, so the claim that quetiapine is clearly highest risk is not well supported, making A at least equally defensible.\\nMain medical accuracy issues: Overstates quetiapine’s anticholinergic danger vs haloperidol; rationale is nonstandard.\\nMinimal fix: Change the keyed answer and explanation to Haloperidol (A) or rewrite the stem to focus explicitly on high anticholinergic burden with stronger comparative justification.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible), with elements of U.\nVerdict on keyed answer: Not uniquely determinable; C is not clearly superior to A.\nKey stem clues: Acute thyrotoxicosis with psychosis; treated with propranolol and methimazole; concern is choosing an antipsychotic that will not worsen thyrotoxicosis-related hyperthermia/hemodynamics. The explanation claims quetiapine’s anticholinergic and α-blocking properties make it most risky.\nMain logical issues: The question asks which antipsychotic most worsens the underlying medical condition (thyrotoxicosis/thyroid storm). Standard board-relevant concern would more strongly implicate haloperidol: risk of neuroleptic malignant syndrome, dopamine blockade potentially interfering with thermoregulation, and known use of high-potency typicals in agitated medically ill patients with caution regarding hyperthermia and QT. Quetiapine’s anticholinergic burden is modest and often considered among the more tolerable atypicals; it is not classically singled out as the worst for hyperthermia in thyrotoxicosis. The item does not provide data on each drug’s relative anticholinergic effect, so the claim that quetiapine is clearly highest risk is not well supported, making A at least equally defensible.\nMain medical accuracy issues: Overstates quetiapine’s anticholinergic danger vs haloperidol; rationale is nonstandard.\nMinimal fix: Change the keyed answer and explanation to Haloperidol (A) or rewrite the stem to focus explicitly on high anticholinergic burden with stronger comparative justification.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-008", "question": "A 67-year-old man undergoes elective right hemicolectomy for a cecal adenocarcinoma. On postoperative day 3, he develops fever (38.9°C), tachycardia, and diffuse abdominal tenderness with guarding. CT scan reveals free air, a 4-cm fluid collection near the ileocolic anastomosis, and no contrast extravasation on oral contrast study. Laboratory studies show WBC 18,400/μL and lactate 3.2 mmol/L. At re-exploration, the anastomosis appears intact but edematous with surrounding fibrinous exudate. There is 400 mL of turbid fluid in the peritoneal cavity. Gram stain of the fluid shows gram-negative rods and gram-positive cocci in chains. Which of the following is the most appropriate surgical management?", "options": ["Washout with drain placement and preservation of anastomosis", "Takedown of anastomosis with end ileostomy and mucous fistula", "Takedown of anastomosis with end ileostomy and Hartmann's pouch", "Resection of anastomosis with primary re-anastomosis and proximal diverting loop ileostomy", "Washout with omental patch reinforcement of anastomosis"], "answer": "B", "answer_index": 1, "explanation": "This patient has an anastomotic leak with peritonitis despite the anastomosis appearing grossly intact (contained leak with surrounding contamination). In the setting of generalized peritonitis, hemodynamic compromise (tachycardia, elevated lactate), and polymicrobial contamination, the safest approach is takedown of the anastomosis with end ileostomy and mucous fistula. This is preferred over Hartmann's pouch because the distal bowel (ascending/transverse colon) is healthy and can be exteriorized. Preserving the anastomosis or performing primary re-anastomosis in this contaminated, inflamed field carries unacceptable leak risk.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: POD3 after right hemicolectomy; fever, tachycardia, diffuse tenderness with guarding (generalized peritonitis); CT with free intraperitoneal air and 4-cm perianastomotic collection; elevated WBC and lactate (systemic inflammatory response); operative findings of turbid intraperitoneal fluid with polymicrobial organisms, edematous anastomosis but no gross disruption. These features indicate an anastomotic leak with generalized peritonitis in a hemodynamically compromised patient, in a markedly contaminated field.\\nOption B—takedown of ileocolic anastomosis with end ileostomy and mucous fistula—is the standard damage-control approach: remove the failed anastomosis and divert in a high-risk, septic abdomen. A and E inappropriately preserve a high-risk anastomosis in gross contamination. D (resection and new anastomosis with diverting ileostomy) still leaves a fresh anastomosis in a hostile field, not appropriate in this unstable, septic context. C (Hartmann’s pouch) is less optimal than B here because the distal colon is healthy and can be exteriorized; mucous fistula is generally preferred when feasible.\\nNo major medical inaccuracies are present; the teaching point aligns with standard colorectal/surgical principles.\\nMinimal fix: Explicitly state he is requiring vasopressors or appears septic/shocky to further justify avoiding any new anastomosis.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: POD3 after right hemicolectomy; fever, tachycardia, diffuse tenderness with guarding (generalized peritonitis); CT with free intraperitoneal air and 4-cm perianastomotic collection; elevated WBC and lactate (systemic inflammatory response); operative findings of turbid intraperitoneal fluid with polymicrobial organisms, edematous anastomosis but no gross disruption. These features indicate an anastomotic leak with generalized peritonitis in a hemodynamically compromised patient, in a markedly contaminated field.\nOption B—takedown of ileocolic anastomosis with end ileostomy and mucous fistula—is the standard damage-control approach: remove the failed anastomosis and divert in a high-risk, septic abdomen. A and E inappropriately preserve a high-risk anastomosis in gross contamination. D (resection and new anastomosis with diverting ileostomy) still leaves a fresh anastomosis in a hostile field, not appropriate in this unstable, septic context. C (Hartmann’s pouch) is less optimal than B here because the distal colon is healthy and can be exteriorized; mucous fistula is generally preferred when feasible.\nNo major medical inaccuracies are present; the teaching point aligns with standard colorectal/surgical principles.\nMinimal fix: Explicitly state he is requiring vasopressors or appears septic/shocky to further justify avoiding any new anastomosis.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-009", "question": "A 52-year-old woman with BMI 48 kg/m² undergoes laparoscopic Roux-en-Y gastric bypass. Eighteen months postoperatively, she has lost 95 pounds and presents with recurrent episodes of postprandial confusion, diaphoresis, and tremor that resolve with eating. Symptoms occur 2-3 hours after meals, particularly those high in simple carbohydrates. Fasting glucose is 78 mg/dL. A mixed meal tolerance test demonstrates glucose of 42 mg/dL with insulin of 28 μU/mL and C-peptide of 6.2 ng/mL at 120 minutes. Calcium-stimulated angiography and selective arterial calcium stimulation testing are negative for insulinoma. Which of the following is the most appropriate next step in management?", "options": ["Diazoxide 100 mg three times daily", "Octreotide 100 mcg subcutaneously before meals", "Acarbose 50 mg with meals", "Completion pancreatectomy", "Reversal of gastric bypass to normal anatomy"], "answer": "C", "answer_index": 2, "explanation": "This patient has post-bariatric hypoglycemia (previously called late dumping syndrome or noninsulinoma pancreatogenous hypoglycemia syndrome). The pathophysiology involves exaggerated GLP-1 secretion leading to inappropriate insulin release after rapid glucose absorption. Acarbose, an alpha-glucosidase inhibitor, slows carbohydrate absorption and reduces the glycemic spike that triggers excessive insulin secretion. It is first-line medical therapy. Diazoxide and octreotide are second-line options with more side effects. Pancreatectomy is reserved for refractory cases. Reversal surgery has high morbidity and variable efficacy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Post–Roux-en-Y (18 months), episodes 2–3 hours after high–simple carbohydrate meals; neuroglycopenic and adrenergic symptoms relieved by food; normal fasting glucose; mixed meal test with marked hypoglycemia and inappropriately elevated insulin and C‑peptide; negative workup for insulinoma. This is classic post–bariatric (post–Roux-en-Y) hyperinsulinemic hypoglycemia. Standard initial management is dietary modification and alpha‑glucosidase inhibition with acarbose to blunt rapid carbohydrate absorption and postprandial glucose spikes, matching the keyed option C.\\nDiazoxide (A) and octreotide (B) are recognized second‑line therapies due to side‑effect burden and less consistent benefit, so they are inferior choices. Completion pancreatectomy (D) is reserved for severe refractory disease because of surgical risks and risk of insulin‑dependent diabetes. Reversal of bypass (E) also has substantial morbidity and uncertain efficacy; it is not first‑line after failure of conservative/medical treatment.\\nThe item is clinically coherent, with one clearly superior answer among reasonable options, and no major pathophysiologic or management inaccuracies.\\nMinimal fix: Explicitly state that dietary modification has been attempted but symptoms persist, to justify proceeding directly to pharmacologic therapy in the stem and align fully with guideline-based sequencing.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Post–Roux-en-Y (18 months), episodes 2–3 hours after high–simple carbohydrate meals; neuroglycopenic and adrenergic symptoms relieved by food; normal fasting glucose; mixed meal test with marked hypoglycemia and inappropriately elevated insulin and C‑peptide; negative workup for insulinoma. This is classic post–bariatric (post–Roux-en-Y) hyperinsulinemic hypoglycemia. Standard initial management is dietary modification and alpha‑glucosidase inhibition with acarbose to blunt rapid carbohydrate absorption and postprandial glucose spikes, matching the keyed option C.\nDiazoxide (A) and octreotide (B) are recognized second‑line therapies due to side‑effect burden and less consistent benefit, so they are inferior choices. Completion pancreatectomy (D) is reserved for severe refractory disease because of surgical risks and risk of insulin‑dependent diabetes. Reversal of bypass (E) also has substantial morbidity and uncertain efficacy; it is not first‑line after failure of conservative/medical treatment.\nThe item is clinically coherent, with one clearly superior answer among reasonable options, and no major pathophysiologic or management inaccuracies.\nMinimal fix: Explicitly state that dietary modification has been attempted but symptoms persist, to justify proceeding directly to pharmacologic therapy in the stem and align fully with guideline-based sequencing.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-010", "question": "A 58-year-old man with type 2 diabetes presents with sudden painless vision loss in his right eye upon awakening. Best-corrected visual acuity is 20/200 OD and 20/25 OS. Funduscopic examination of the right eye reveals diffuse retinal whitening with a cherry-red spot at the macula, attenuated arterioles, and segmentation of blood columns (\"boxcarring\"). Intraocular pressure is 14 mmHg OD and 15 mmHg OS. Carotid duplex shows 40% stenosis of the right internal carotid artery. Echocardiogram reveals no intracardiac thrombus. The patient presents 3 hours after symptom onset. Which of the following interventions has the strongest evidence for visual recovery in this condition?", "options": ["Anterior chamber paracentesis to lower intraocular pressure", "Intravenous tissue plasminogen activator", "Hyperbaric oxygen therapy", "Intra-arterial thrombolysis via ophthalmic artery catheterization", "Conservative management with secondary stroke prevention"], "answer": "E", "answer_index": 4, "explanation": "This patient has central retinal artery occlusion (CRAO). Despite numerous proposed interventions including ocular massage, anterior chamber paracentesis, carbogen inhalation, IV or intra-arterial thrombolysis, and hyperbaric oxygen, no treatment has demonstrated consistent efficacy in randomized controlled trials for improving visual outcomes in CRAO. The EAGLE study found no benefit of intra-arterial thrombolysis. Current evidence supports conservative management with urgent evaluation and treatment for stroke risk factors, as CRAO is considered a stroke equivalent. Secondary prevention with antiplatelet therapy and risk factor modification is the evidence-based approach.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: U/M (underspecified leading to multiple defensible answers)\\nVerdict on keyed answer: Not uniquely determinable\\nKey stem clues: Sudden, painless, monocular vision loss upon awakening; fundus with diffuse retinal whitening, cherry-red spot, boxcarring—classic central retinal artery occlusion (CRAO). Presentation is at 3 hours from onset. Question asks specifically: “Which intervention has the strongest evidence for visual recovery in this condition?”\\nMain logical issues: The stem explicitly focuses on *visual recovery* in acute CRAO, not overall management or stroke prevention. Option E (conservative management with secondary stroke prevention) has essentially no evidence for improving *visual recovery*; it is for systemic risk reduction. Among the other options, hyperbaric oxygen therapy (C) has some supportive albeit limited evidence for improved visual outcomes in selected CRAO patients within a short time window. Thus E is not defensible as the best answer to the stated question; at least C is reasonably defensible, creating a miskey/underspecification problem. The explanation also shifts the target to long-term systemic management, misaligned with the stem’s wording.\\nMain medical accuracy issues: Overstates “no treatment has demonstrated consistent efficacy,” downplaying existing albeit limited evidence for HBO.\\nMinimal fix: Rephrase stem to ask for “overall evidence-based management priority” or change key to C and adjust rationale accordingly.\",\"medical_accuracy_score\":\"3\",\"logical_validity\":false,\"logical_false_reason\":\"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U/M (underspecified leading to multiple defensible answers)\nVerdict on keyed answer: Not uniquely determinable\nKey stem clues: Sudden, painless, monocular vision loss upon awakening; fundus with diffuse retinal whitening, cherry-red spot, boxcarring—classic central retinal artery occlusion (CRAO). Presentation is at 3 hours from onset. Question asks specifically: “Which intervention has the strongest evidence for visual recovery in this condition?”\nMain logical issues: The stem explicitly focuses on *visual recovery* in acute CRAO, not overall management or stroke prevention. Option E (conservative management with secondary stroke prevention) has essentially no evidence for improving *visual recovery*; it is for systemic risk reduction. Among the other options, hyperbaric oxygen therapy (C) has some supportive albeit limited evidence for improved visual outcomes in selected CRAO patients within a short time window. Thus E is not defensible as the best answer to the stated question; at least C is reasonably defensible, creating a miskey/underspecification problem. The explanation also shifts the target to long-term systemic management, misaligned with the stem’s wording.\nMain medical accuracy issues: Overstates “no treatment has demonstrated consistent efficacy,” downplaying existing albeit limited evidence for HBO.\nMinimal fix: Rephrase stem to ask for “overall evidence-based management priority” or change key to C and adjust rationale accordingly.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-011", "question": "A 6-year-old boy presents with progressive gait instability, frequent falls, and difficulty climbing stairs over the past year. Physical examination reveals calf pseudohypertrophy, positive Gowers' sign, and proximal muscle weakness. Creatine kinase is 15,400 U/L. Genetic testing confirms a deletion in the dystrophin gene consistent with Duchenne muscular dystrophy. Echocardiogram shows normal left ventricular function. The family asks about disease-modifying therapy. The child weighs 22 kg. Which of the following treatments is most likely to slow disease progression in this patient?", "options": ["Deflazacort 0.9 mg/kg/day", "Eteplirsen 30 mg/kg weekly intravenously", "Ataluren 40 mg/kg/day in three divided doses", "Golodirsen 30 mg/kg weekly intravenously", "Idebenone 900 mg daily"], "answer": "A", "answer_index": 0, "explanation": "Deflazacort (and prednisone) are the only treatments with robust evidence demonstrating slowed disease progression in Duchenne muscular dystrophy, including prolonged ambulation, preserved pulmonary function, and delayed cardiomyopathy. Deflazacort may have a slightly better side effect profile than prednisone. Exon-skipping therapies (eteplirsen, golodirsen) are only applicable to specific mutations amenable to exon skipping and have shown only modest dystrophin production without clear clinical benefit. Ataluren is for nonsense mutations only. Idebenone showed no benefit in the DELOS trial for patients on corticosteroids.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 6-year-old boy with genetically confirmed Duchenne muscular dystrophy (DMD), ambulatory with proximal weakness and classic DMD findings, normal LV function, family asking for disease‑modifying therapy now. No information that his mutation is a nonsense mutation or is amenable to a specific exon-skipping strategy. Therefore, the only universally applicable, guideline-supported disease-modifying therapy is chronic corticosteroids.\\nOption A (deflazacort 0.9 mg/kg/day) matches standard first-line dosing and has strong evidence for slowing progression (prolonged ambulation, pulmonary and cardiac benefit). Options B (eteplirsen) and D (golodirsen) are only indicated for specific exon 51/53 amenable deletions and require that mutation detail, which is absent, and clinical benefit remains modest. Option C (ataluren) applies only to nonsense mutations, not specified here. Option E (idebenone) lacks convincing evidence of benefit in steroid-treated patients per major trials.\\nThere is a single best choice under typical exam assumptions that mutation-specific therapies are not chosen without explicit genetic suitability.\\nMedical accuracy is strong and aligned with current consensus.\\nMinimal fix: Explicitly state that the patient’s mutation is not amenable to exon-skipping or a nonsense mutation to further clarify why corticosteroids are preferred here.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 6-year-old boy with genetically confirmed Duchenne muscular dystrophy (DMD), ambulatory with proximal weakness and classic DMD findings, normal LV function, family asking for disease‑modifying therapy now. No information that his mutation is a nonsense mutation or is amenable to a specific exon-skipping strategy. Therefore, the only universally applicable, guideline-supported disease-modifying therapy is chronic corticosteroids.\nOption A (deflazacort 0.9 mg/kg/day) matches standard first-line dosing and has strong evidence for slowing progression (prolonged ambulation, pulmonary and cardiac benefit). Options B (eteplirsen) and D (golodirsen) are only indicated for specific exon 51/53 amenable deletions and require that mutation detail, which is absent, and clinical benefit remains modest. Option C (ataluren) applies only to nonsense mutations, not specified here. Option E (idebenone) lacks convincing evidence of benefit in steroid-treated patients per major trials.\nThere is a single best choice under typical exam assumptions that mutation-specific therapies are not chosen without explicit genetic suitability.\nMedical accuracy is strong and aligned with current consensus.\nMinimal fix: Explicitly state that the patient’s mutation is not amenable to exon-skipping or a nonsense mutation to further clarify why corticosteroids are preferred here.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-012", "question": "A 24-year-old man is brought to the emergency department after being rescued from a house fire. He has extensive full-thickness burns covering an estimated 65% total body surface area. He is intubated in the field for airway protection. Initial resuscitation is begun with lactated Ringer's solution using the Parkland formula. Six hours into resuscitation, he has received 14 liters of crystalloid. Vital signs: BP 88/52 mmHg, HR 132 bpm. Urine output over the past 2 hours is 15 mL total. Bladder pressure is 32 mmHg. Peak airway pressures have increased from 28 to 48 cmH2O. Which of the following is the most appropriate next step?", "options": ["Increase crystalloid infusion rate by 50%", "Add albumin 5% to resuscitation fluids", "Perform bilateral chest escharotomies", "Perform decompressive laparotomy", "Perform bedside abdominal escharotomy"], "answer": "E", "answer_index": 4, "explanation": "This patient has developed abdominal compartment syndrome (ACS) in the setting of massive burn resuscitation, evidenced by oliguria, hypotension, elevated bladder pressure (>20 mmHg with organ dysfunction), and elevated airway pressures. In burn patients with circumferential or near-circumferential truncal burns, abdominal escharotomy can effectively decompress the abdomen without the morbidity of laparotomy. This should be attempted before decompressive laparotomy. Increasing crystalloid will worsen edema and compartment pressures. Chest escharotomies address thoracic restriction but not abdominal compartment syndrome. Albumin may reduce total fluid requirements but won't acutely address ACS.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 65% TBSA full-thickness burns, massive crystalloid (14 L in 6 hours), hypotension, tachycardia, oliguria, markedly elevated bladder pressure (32 mmHg) with organ dysfunction, and rising peak airway pressures. These findings define abdominal compartment syndrome (IAP >20 mmHg plus organ dysfunction) in the setting of large-volume burn resuscitation. The vignette implies circumferential or near-circumferential truncal burns (typical in this context), making escharotomy a logical first decompressive step.\\nOption analysis: A (increase crystalloid) would exacerbate edema and ACS. B (albumin) might help fluid balance later but does not acutely relieve compartment pressure. C (chest escharotomies) addresses thoracic constriction, not intra-abdominal hypertension. D (decompressive laparotomy) is indicated if less invasive decompression fails or if no eschar is present; here, abdominal escharotomy is the lower-morbidity first approach. E (bedside abdominal escharotomy) directly treats ACS in a burned abdomen and matches standard burn/critical care teaching.\\nMain medical accuracy issues: None significant; explanation matches current understanding of ACS management in burn patients.\\nMinimal fix: Explicitly state the patient has circumferential abdominal/truncal burns to fully justify abdominal escharotomy as first-line decompression.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 65% TBSA full-thickness burns, massive crystalloid (14 L in 6 hours), hypotension, tachycardia, oliguria, markedly elevated bladder pressure (32 mmHg) with organ dysfunction, and rising peak airway pressures. These findings define abdominal compartment syndrome (IAP >20 mmHg plus organ dysfunction) in the setting of large-volume burn resuscitation. The vignette implies circumferential or near-circumferential truncal burns (typical in this context), making escharotomy a logical first decompressive step.\nOption analysis: A (increase crystalloid) would exacerbate edema and ACS. B (albumin) might help fluid balance later but does not acutely relieve compartment pressure. C (chest escharotomies) addresses thoracic constriction, not intra-abdominal hypertension. D (decompressive laparotomy) is indicated if less invasive decompression fails or if no eschar is present; here, abdominal escharotomy is the lower-morbidity first approach. E (bedside abdominal escharotomy) directly treats ACS in a burned abdomen and matches standard burn/critical care teaching.\nMain medical accuracy issues: None significant; explanation matches current understanding of ACS management in burn patients.\nMinimal fix: Explicitly state the patient has circumferential abdominal/truncal burns to fully justify abdominal escharotomy as first-line decompression.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-013", "question": "A 45-year-old woman with myasthenia gravis (anti-acetylcholine receptor antibody positive) on pyridostigmine and prednisone is scheduled for thymectomy. She reports mild dyspnea with exertion and occasional dysphagia. Forced vital capacity is 1.8 L (62% predicted). On the morning of surgery, she takes her usual pyridostigmine dose. After uneventful induction with propofol and fentanyl, the anesthesiologist administers rocuronium 0.6 mg/kg for intubation. The surgery proceeds without complication. At the end of the case, train-of-four monitoring shows 2/4 twitches. Sugammadex 4 mg/kg is administered. Five minutes later, train-of-four ratio is 0.95 and the patient is extubated. In the PACU, she develops progressive respiratory distress, paradoxical breathing, and oxygen desaturation. ABG shows pH 7.28, PaCO2 62 mmHg, PaO2 58 mmHg on 6L nasal cannula. Which of the following is the most likely cause of her respiratory failure?", "options": ["Residual neuromuscular blockade from rocuronium", "Sugammadex-induced anaphylaxis", "Myasthenic crisis precipitated by surgical stress", "Cholinergic crisis from pyridostigmine", "Unilateral phrenic nerve injury during thymectomy"], "answer": "C", "answer_index": 2, "explanation": "This patient is experiencing myasthenic crisis, an exacerbation of myasthenia gravis causing respiratory failure. Surgical stress, particularly thymectomy, is a well-known precipitant. The adequate train-of-four ratio (0.95) after sugammadex rules out residual neuromuscular blockade. Sugammadex anaphylaxis would present with cardiovascular collapse and bronchospasm, not isolated hypercapnic respiratory failure. Cholinergic crisis would present with excessive secretions, miosis, bradycardia, and fasciculations. Unilateral phrenic nerve injury rarely causes this degree of respiratory compromise. The hypercapnic respiratory failure pattern indicates neuromuscular weakness affecting respiratory muscles.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Known myasthenia gravis on pyridostigmine and prednisone; thymectomy (common trigger of postoperative myasthenic crisis); preoperative mild bulbar/respiratory symptoms and reduced FVC (62% predicted); intraoperative rocuronium reversed with sugammadex to TOF ratio 0.95; initial smooth extubation; then delayed progressive respiratory distress with paradoxical breathing and hypercapnic respiratory failure (PaCO2 62) in PACU; no mention of bronchospasm, hypotension, or muscarinic excess.\\nThese findings strongly support postoperative myasthenic crisis due to respiratory muscle weakness, making C the single best answer. Residual neuromuscular blockade (A) is unlikely with TOF ratio 0.95 after appropriate sugammadex dose; while rare false reassurance is possible, exam convention accepts ≥0.9 as adequate. Sugammadex anaphylaxis (B) would cause acute hypotension, tachycardia, rash, bronchospasm, and usually immediate onset, not isolated hypercapnia. Cholinergic crisis (D) would show miosis, bradycardia, diarrhea, salivation, bronchorrhea, and fasciculations, none described. Unilateral phrenic nerve injury (E) is usually insufficient to cause severe hypercapnic failure in an otherwise stable patient.\\nMain medical issues: Scenario and explanations are consistent with standard MG/anesthesia teaching. \\nMinimal fix: Add explicit timing (“1–2 hours after extubation…”) and a normal blood pressure/heart rate statement to further exclude anaphylaxis and residual blockade ambiguity.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Known myasthenia gravis on pyridostigmine and prednisone; thymectomy (common trigger of postoperative myasthenic crisis); preoperative mild bulbar/respiratory symptoms and reduced FVC (62% predicted); intraoperative rocuronium reversed with sugammadex to TOF ratio 0.95; initial smooth extubation; then delayed progressive respiratory distress with paradoxical breathing and hypercapnic respiratory failure (PaCO2 62) in PACU; no mention of bronchospasm, hypotension, or muscarinic excess.\nThese findings strongly support postoperative myasthenic crisis due to respiratory muscle weakness, making C the single best answer. Residual neuromuscular blockade (A) is unlikely with TOF ratio 0.95 after appropriate sugammadex dose; while rare false reassurance is possible, exam convention accepts ≥0.9 as adequate. Sugammadex anaphylaxis (B) would cause acute hypotension, tachycardia, rash, bronchospasm, and usually immediate onset, not isolated hypercapnia. Cholinergic crisis (D) would show miosis, bradycardia, diarrhea, salivation, bronchorrhea, and fasciculations, none described. Unilateral phrenic nerve injury (E) is usually insufficient to cause severe hypercapnic failure in an otherwise stable patient.\nMain medical issues: Scenario and explanations are consistent with standard MG/anesthesia teaching. \nMinimal fix: Add explicit timing (“1–2 hours after extubation…”) and a normal blood pressure/heart rate statement to further exclude anaphylaxis and residual blockade ambiguity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-014", "question": "A 68-year-old man with severe COPD (FEV1 28% predicted) undergoes right upper lobectomy for non-small cell lung cancer under general anesthesia with one-lung ventilation using a left-sided double-lumen tube. During one-lung ventilation of the left lung, SpO2 drops to 84% despite FiO2 1.0. Fiberoptic bronchoscopy confirms correct tube position. Tidal volume is 350 mL, respiratory rate 14/min, PEEP 5 cmH2O. Peak airway pressure is 38 cmH2O. ABG shows PaO2 52 mmHg, PaCO2 58 mmHg. Which of the following interventions is most likely to improve oxygenation?", "options": ["Apply CPAP 5 cmH2O to the non-ventilated (operative) lung", "Increase PEEP to 10 cmH2O on the ventilated lung", "Increase tidal volume to 500 mL", "Administer inhaled nitric oxide to the ventilated lung", "Clamp the pulmonary artery of the operative lung"], "answer": "A", "answer_index": 0, "explanation": "Hypoxemia during one-lung ventilation results primarily from shunt through the non-ventilated lung. Applying CPAP (typically 5-10 cmH2O) to the non-ventilated lung provides oxygen to the collapsed lung and recruits some alveoli, reducing shunt fraction while minimally interfering with surgical exposure. Increasing PEEP on the ventilated lung may overdistend already hyperinflated COPD lung and divert blood flow to the non-ventilated lung, worsening shunt. Increasing tidal volume risks barotrauma. Inhaled nitric oxide to the ventilated lung improves V/Q matching but is less effective than addressing the shunt directly. Pulmonary artery clamping is invasive and typically reserved for pneumonectomy.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Severe COPD (FEV1 28%), one-lung ventilation with correct left-sided DLT position confirmed; significant hypoxemia (SpO2 84%, PaO2 52 on FiO2 1.0) and hypercapnia; modest PEEP (5 cmH2O) and relatively high peak pressure (38 cmH2O). The primary mechanism of hypoxemia during OLV is shunt through the non-ventilated lung. Applying low-level CPAP with oxygen to the non-ventilated (operative) lung is textbook first-line when FiO2 is already 1.0 and positioning/tube placement are adequate, directly reducing shunt while generally preserving surgical exposure.\\nOption B (increase PEEP) risks further hyperinflation/overdistension of the severe COPD ventilated lung, potentially worsening V/Q mismatch by diverting flow to the non-ventilated lung. Option C (increase VT) risks barotrauma and higher pressures without shunt correction. Option D (iNO) may help V/Q matching but is not as direct or standard as CPAP to the non-ventilated lung. Option E (pulmonary artery clamping) is invasive and not routine for lobectomy solely to manage hypoxemia.\\nNo major medical inaccuracies are present; teaching point aligns with thoracic anesthesia standards.\\nMinimal fix: Specify that surgical field allows application of low-level CPAP to the operative lung to preempt concerns about exposure limitations.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Severe COPD (FEV1 28%), one-lung ventilation with correct left-sided DLT position confirmed; significant hypoxemia (SpO2 84%, PaO2 52 on FiO2 1.0) and hypercapnia; modest PEEP (5 cmH2O) and relatively high peak pressure (38 cmH2O). The primary mechanism of hypoxemia during OLV is shunt through the non-ventilated lung. Applying low-level CPAP with oxygen to the non-ventilated (operative) lung is textbook first-line when FiO2 is already 1.0 and positioning/tube placement are adequate, directly reducing shunt while generally preserving surgical exposure.\nOption B (increase PEEP) risks further hyperinflation/overdistension of the severe COPD ventilated lung, potentially worsening V/Q mismatch by diverting flow to the non-ventilated lung. Option C (increase VT) risks barotrauma and higher pressures without shunt correction. Option D (iNO) may help V/Q matching but is not as direct or standard as CPAP to the non-ventilated lung. Option E (pulmonary artery clamping) is invasive and not routine for lobectomy solely to manage hypoxemia.\nNo major medical inaccuracies are present; teaching point aligns with thoracic anesthesia standards.\nMinimal fix: Specify that surgical field allows application of low-level CPAP to the operative lung to preempt concerns about exposure limitations.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-015", "question": "A 35-year-old woman with no psychiatric history presents with acute onset of bizarre behavior, visual hallucinations, and seizures over 3 days. She has no fever. MRI brain shows bilateral medial temporal lobe T2 hyperintensities. CSF analysis reveals lymphocytic pleocytosis (45 cells/μL), elevated protein (68 mg/dL), and normal glucose. EEG shows extreme delta brush pattern. Anti-NMDA receptor antibodies return positive in CSF. CT of chest, abdomen, and pelvis reveals a 4-cm right ovarian mass. After tumor resection (pathology confirms ovarian teratoma), she receives first-line immunotherapy with high-dose corticosteroids, IVIG, and plasmapheresis. At week 6, she remains comatose with persistent seizures. Which of the following is the most appropriate next step in management?", "options": ["Continue current immunotherapy regimen for additional 6 weeks", "Initiate rituximab 375 mg/m² weekly for 4 doses", "Initiate cyclophosphamide 750 mg/m² monthly", "Initiate rituximab and cyclophosphamide combination therapy", "Initiate intrathecal methotrexate"], "answer": "D", "answer_index": 3, "explanation": "Anti-NMDA receptor encephalitis refractory to first-line therapy (tumor removal, corticosteroids, IVIG, and/or plasmapheresis) requires escalation to second-line immunotherapy. Current evidence and expert consensus support combination rituximab and cyclophosphamide as second-line therapy for refractory cases, as this combination targets both B-cell mediated antibody production and provides broader immunosuppression. Using either agent alone is less effective in severe refractory cases. Continuing first-line therapy alone when there is no response at 6 weeks delays effective treatment. Intrathecal methotrexate is not standard therapy for autoimmune encephalitis.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Young woman; classic anti-NMDA receptor encephalitis features (psychiatric symptoms, seizures, temporal lobe MRI changes, lymphocytic CSF, extreme delta brush EEG, positive CSF anti-NMDA Ab); associated ovarian teratoma resected; has already received appropriate first-line immunotherapy (high-dose steroids, IVIG, plasmapheresis); remains comatose with seizures at 6 weeks, indicating refractory disease. The question asks for the next step in management for refractory anti-NMDA receptor encephalitis.\\nD (rituximab + cyclophosphamide) is consistent with widely accepted practice and consensus: second-line therapy for severe refractory cases often combines anti-CD20 B-cell depletion (rituximab) with cyclophosphamide for broader immunosuppression. A is inappropriate because lack of response at 6 weeks suggests first-line failure. B or C alone are plausible but generally considered less aggressive/effective than combined therapy in severe refractory disease; thus they are inferior answers in this framing. E (intrathecal methotrexate) is not a standard treatment for autoimmune encephalitis.\\nMain medical issue: minor nuance—some centers may use rituximab alone, but combination is well-supported for severe refractory cases. Minimal fix: Specify “severe refractory disease with no improvement after 4–6 weeks of first-line therapy” in the stem to emphasize need for second-line combination therapy.\\n\",\"medical_accuracy_score\":\"4\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Young woman; classic anti-NMDA receptor encephalitis features (psychiatric symptoms, seizures, temporal lobe MRI changes, lymphocytic CSF, extreme delta brush EEG, positive CSF anti-NMDA Ab); associated ovarian teratoma resected; has already received appropriate first-line immunotherapy (high-dose steroids, IVIG, plasmapheresis); remains comatose with seizures at 6 weeks, indicating refractory disease. The question asks for the next step in management for refractory anti-NMDA receptor encephalitis.\nD (rituximab + cyclophosphamide) is consistent with widely accepted practice and consensus: second-line therapy for severe refractory cases often combines anti-CD20 B-cell depletion (rituximab) with cyclophosphamide for broader immunosuppression. A is inappropriate because lack of response at 6 weeks suggests first-line failure. B or C alone are plausible but generally considered less aggressive/effective than combined therapy in severe refractory disease; thus they are inferior answers in this framing. E (intrathecal methotrexate) is not a standard treatment for autoimmune encephalitis.\nMain medical issue: minor nuance—some centers may use rituximab alone, but combination is well-supported for severe refractory cases. Minimal fix: Specify “severe refractory disease with no improvement after 4–6 weeks of first-line therapy” in the stem to emphasize need for second-line combination therapy.\n", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-016", "question": "A 72-year-old man with major depressive disorder has failed adequate trials of sertraline, venlafaxine, and mirtazapine augmented with aripiprazole. He has no psychotic features. Medical history includes coronary artery disease with drug-eluting stent placed 8 months ago (on aspirin and clopidogrel), hypertension, and benign prostatic hyperplasia. He is referred for electroconvulsive therapy (ECT). Pre-ECT cardiac evaluation shows EF 55% with no active ischemia. Which of the following medication adjustments is most appropriate before initiating ECT?", "options": ["Discontinue clopidogrel 7 days before first ECT session", "Hold aspirin on the morning of each ECT session", "Continue dual antiplatelet therapy without modification", "Bridge with enoxaparin after stopping clopidogrel", "Switch clopidogrel to ticagrelor for shorter half-life"], "answer": "C", "answer_index": 2, "explanation": "Current evidence and guidelines support continuing dual antiplatelet therapy (DAPT) during ECT. The risk of stent thrombosis from discontinuing antiplatelet therapy within 12 months of drug-eluting stent placement significantly outweighs the minimal bleeding risk associated with ECT. ECT does not involve surgical incisions, and intracranial hemorrhage during ECT is exceedingly rare even on anticoagulation. Discontinuing or bridging antiplatelet therapy is not recommended. The transient hypertension during ECT seizure is manageable with appropriate anesthetic technique and does not contraindicate the procedure in stable coronary disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 72-year-old with treatment-resistant major depression, nonpsychotic; drug-eluting coronary stent placed 8 months ago; on aspirin + clopidogrel; pre-ECT cardiac workup reassuring (EF 55%, no active ischemia). Question asks which medication adjustment is appropriate before ECT. Evidence and peri-ECT guidance indicate that ECT has very low bleeding risk, including on antiplatelets/anticoagulants, whereas stopping DAPT within 12 months of a drug-eluting stent carries significant stent thrombosis/MI risk. Therefore, continuing dual antiplatelet therapy is the single best answer.\\nOption analysis: A (stop clopidogrel) and B (hold aspirin) both inappropriately interrupt DAPT despite high thrombosis risk and minimal ECT bleeding risk. D (bridge with enoxaparin) is not appropriate for antiplatelet therapy and would increase bleeding risk without protecting against stent thrombosis. E (switch to ticagrelor) introduces unnecessary change with no ECT-related benefit and potential new risks. C correctly reflects current practice: continue DAPT unchanged.\\nMain medical accuracy issues: None; explanation is consistent with modern evidence and practice.\\nMinimal fix: Add a brief statement that platelet counts and coagulation profile are normal to preempt irrelevant bleeding-disorder concerns, though not strictly necessary for validity.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 72-year-old with treatment-resistant major depression, nonpsychotic; drug-eluting coronary stent placed 8 months ago; on aspirin + clopidogrel; pre-ECT cardiac workup reassuring (EF 55%, no active ischemia). Question asks which medication adjustment is appropriate before ECT. Evidence and peri-ECT guidance indicate that ECT has very low bleeding risk, including on antiplatelets/anticoagulants, whereas stopping DAPT within 12 months of a drug-eluting stent carries significant stent thrombosis/MI risk. Therefore, continuing dual antiplatelet therapy is the single best answer.\nOption analysis: A (stop clopidogrel) and B (hold aspirin) both inappropriately interrupt DAPT despite high thrombosis risk and minimal ECT bleeding risk. D (bridge with enoxaparin) is not appropriate for antiplatelet therapy and would increase bleeding risk without protecting against stent thrombosis. E (switch to ticagrelor) introduces unnecessary change with no ECT-related benefit and potential new risks. C correctly reflects current practice: continue DAPT unchanged.\nMain medical accuracy issues: None; explanation is consistent with modern evidence and practice.\nMinimal fix: Add a brief statement that platelet counts and coagulation profile are normal to preempt irrelevant bleeding-disorder concerns, though not strictly necessary for validity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-017", "question": "A 19-year-old college student is brought to the emergency department by campus police after being found in her dormitory room with superficial lacerations on both forearms. She reports cutting herself \"to feel something\" after her boyfriend ended their 2-month relationship. She denies suicidal ideation and states she \"would never actually kill herself.\" She describes a pattern of intense, unstable relationships, chronic feelings of emptiness, and impulsive behaviors including binge eating and reckless driving. She has had multiple similar presentations over the past 3 years. Mental status examination reveals dramatic affect with rapid shifts between tearfulness and anger. Which of the following is the most appropriate disposition?", "options": ["Involuntary psychiatric hospitalization for imminent self-harm risk", "Voluntary psychiatric hospitalization for stabilization", "Discharge with outpatient dialectical behavior therapy referral", "Discharge with outpatient psychodynamic psychotherapy referral", "23-hour observation unit placement with crisis intervention"], "answer": "C", "answer_index": 2, "explanation": "This patient presents with borderline personality disorder (BPD) with non-suicidal self-injury (NSSI). Evidence strongly supports that psychiatric hospitalization for NSSI in BPD is generally not beneficial and may be harmful by reinforcing maladaptive behaviors and disrupting outpatient treatment. Dialectical behavior therapy (DBT) is the most evidence-based treatment for BPD and specifically targets self-harm behaviors. The patient denies suicidal intent, has a pattern consistent with NSSI rather than suicide attempts, and does not meet criteria for involuntary commitment. Outpatient DBT referral with appropriate safety planning is the standard of care.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 19-year-old with chronic pattern of unstable intense relationships, impulsivity, chronic emptiness, dramatic lability, and recurrent superficial cutting “to feel something,” multiple similar ED presentations over 3 years, explicit denial of suicidal intent and statement she “would never actually kill herself,” no mention of psychosis, intoxication, or inability to contract for safety. This is classic borderline personality disorder with non-suicidal self-injury rather than an acute suicide attempt.\\nOptions A/B (involuntary/voluntary hospitalization) are weaker because there is no clear evidence of imminent suicide risk or inability to be safely managed as outpatient; guidelines caution against routine hospitalization for NSSI in stable BPD. Option D (psychodynamic therapy) is less evidence-based for BPD core symptoms and NSSI than DBT. Option E (23-hour observation) is not necessary given chronicity, stability, and lack of acute escalation.\\nMedical accuracy is high: DBT is first-line, hospitalization for BPD NSSI is generally avoided unless acute suicidal intent/plan is present. Minimal fix: Explicitly state that risk assessment finds no suicidal plan/intent and that a responsible adult is available to supervise post-discharge, to further justify outpatient disposition.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 19-year-old with chronic pattern of unstable intense relationships, impulsivity, chronic emptiness, dramatic lability, and recurrent superficial cutting “to feel something,” multiple similar ED presentations over 3 years, explicit denial of suicidal intent and statement she “would never actually kill herself,” no mention of psychosis, intoxication, or inability to contract for safety. This is classic borderline personality disorder with non-suicidal self-injury rather than an acute suicide attempt.\nOptions A/B (involuntary/voluntary hospitalization) are weaker because there is no clear evidence of imminent suicide risk or inability to be safely managed as outpatient; guidelines caution against routine hospitalization for NSSI in stable BPD. Option D (psychodynamic therapy) is less evidence-based for BPD core symptoms and NSSI than DBT. Option E (23-hour observation) is not necessary given chronicity, stability, and lack of acute escalation.\nMedical accuracy is high: DBT is first-line, hospitalization for BPD NSSI is generally avoided unless acute suicidal intent/plan is present. Minimal fix: Explicitly state that risk assessment finds no suicidal plan/intent and that a responsible adult is available to supervise post-discharge, to further justify outpatient disposition.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-018", "question": "A 48-year-old woman undergoes total thyroidectomy for papillary thyroid carcinoma. The surgeon identifies and preserves both recurrent laryngeal nerves using intraoperative nerve monitoring. Twelve hours postoperatively, she develops progressive dyspnea, stridor, and neck swelling. Oxygen saturation is 88% on room air. The surgical site shows tense swelling with ecchymosis. Bedside flexible laryngoscopy reveals bilateral vocal cord immobility in the paramedian position with adequate glottic airway. Which of the following is the most appropriate immediate management?", "options": ["Emergent wound exploration and hematoma evacuation at bedside", "Emergent return to operating room for wound exploration", "Emergent awake tracheostomy under local anesthesia", "Emergent cricothyroidotomy", "Endotracheal intubation followed by wound exploration"], "answer": "A", "answer_index": 0, "explanation": "Post-thyroidectomy hematoma with airway compromise is a surgical emergency requiring immediate wound exploration and hematoma evacuation. When the patient has stridor and respiratory distress from neck hematoma, opening the wound at bedside (even in the absence of full surgical setup) is the fastest way to decompress the airway. This can be performed by opening skin staples/sutures and evacuating clot, which immediately relieves tracheal compression. Waiting for OR availability or attempting intubation in a patient with distorted anatomy and bilateral vocal cord paralysis risks complete airway loss. Tracheostomy and cricothyroidotomy are more invasive and time-consuming than simple wound opening.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: Recent total thyroidectomy, rapid-onset dyspnea/stridor 12 hours postop, tense neck swelling with ecchymosis, oxygen saturation 88% on room air, and exam consistent with compressive neck hematoma (tense swelling) rather than glottic obstruction (laryngoscopy shows bilateral cords paramedian but with adequate glottic airway). The core emergency is external tracheal compression from hematoma.\\nLogical analysis: In post-thyroidectomy patients with airway compromise from neck hematoma, standard teaching is that the priority is immediate decompression of the wound, even at bedside, because delay for OR setup can result in complete airway loss; this fits option A. Option B (return to OR) is too slow given current airway compromise. Option E (intubation then explore) is risky and often not feasible because hematoma/edema distort anatomy and intubation attempts may precipitate total obstruction. Options C and D (tracheostomy, cricothyrotomy) are invasive rescue procedures reserved if simple decompression fails; they are not first step given the obvious, rapidly reversible cause.\\nMedical accuracy: The airway/anatomy reasoning and management priority are consistent with contemporary surgical and anesthetic guidance.\\nMinimal fix: None required; item is clear. Could add phrase “immediate bedside management” to reinforce timing, but not essential.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: Recent total thyroidectomy, rapid-onset dyspnea/stridor 12 hours postop, tense neck swelling with ecchymosis, oxygen saturation 88% on room air, and exam consistent with compressive neck hematoma (tense swelling) rather than glottic obstruction (laryngoscopy shows bilateral cords paramedian but with adequate glottic airway). The core emergency is external tracheal compression from hematoma.\nLogical analysis: In post-thyroidectomy patients with airway compromise from neck hematoma, standard teaching is that the priority is immediate decompression of the wound, even at bedside, because delay for OR setup can result in complete airway loss; this fits option A. Option B (return to OR) is too slow given current airway compromise. Option E (intubation then explore) is risky and often not feasible because hematoma/edema distort anatomy and intubation attempts may precipitate total obstruction. Options C and D (tracheostomy, cricothyrotomy) are invasive rescue procedures reserved if simple decompression fails; they are not first step given the obvious, rapidly reversible cause.\nMedical accuracy: The airway/anatomy reasoning and management priority are consistent with contemporary surgical and anesthetic guidance.\nMinimal fix: None required; item is clear. Could add phrase “immediate bedside management” to reinforce timing, but not essential.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-019", "question": "A 55-year-old man with cirrhosis secondary to hepatitis C (Child-Pugh class B, MELD score 18) presents with a 3-cm hepatocellular carcinoma in segment VI, discovered on surveillance imaging. He has no extrahepatic disease and no macrovascular invasion. Portal vein is patent. He has moderate ascites controlled with diuretics and no history of hepatic encephalopathy. Performance status is ECOG 0. The hepatology tumor board discusses treatment options. According to the Barcelona Clinic Liver Cancer (BCLC) staging system, which of the following is the most appropriate treatment recommendation?", "options": ["Liver transplantation", "Surgical resection", "Radiofrequency ablation", "Transarterial chemoembolization", "Sorafenib"], "answer": "A", "answer_index": 0, "explanation": "This patient has BCLC stage A (early HCC) with a single tumor ≤3 cm, but with Child-Pugh B cirrhosis and portal hypertension (evidenced by ascites). According to BCLC guidelines, surgical resection is only recommended for patients with preserved liver function (Child-Pugh A) without portal hypertension. For patients with early HCC and impaired liver function, liver transplantation is the preferred treatment as it addresses both the tumor and underlying liver disease. This patient meets Milan criteria (single tumor ≤5 cm). Ablation is an alternative for non-transplant candidates. TACE is for intermediate stage, and sorafenib for advanced stage disease.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\nKey stem clues: 3‑cm solitary HCC, no macrovascular invasion or extrahepatic spread; portal vein patent; underlying HCV cirrhosis Child‑Pugh B; presence of portal hypertension (moderate ascites); ECOG 0. By BCLC, this is early-stage (stage A) HCC with impaired liver function and portal hypertension. Resection is reserved for patients with preserved liver function (Child-Pugh A) and no portal hypertension; thus option B is inappropriate. For early HCC within Milan criteria and decompensated/portal hypertensive cirrhosis, liver transplantation is the recommended curative therapy, matching option A. Ablation (C) is generally for small tumors in patients who are not transplant candidates or as bridge/downstaging, so it is inferior here. TACE (D) is for intermediate (BCLC B) multinodular disease, not single early tumor. Sorafenib (E) is systemic therapy for advanced HCC (BCLC C). The explanation correctly aligns with widely accepted BCLC guidance.\\nMain medical accuracy issue(s): None significant; content is guideline-consistent.\\nMinimal fix: Optionally, explicitly state “meets Milan criteria” or “BCLC stage A” in the stem to make the staging assumption explicit, though not strictly necessary.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\nKey stem clues: 3‑cm solitary HCC, no macrovascular invasion or extrahepatic spread; portal vein patent; underlying HCV cirrhosis Child‑Pugh B; presence of portal hypertension (moderate ascites); ECOG 0. By BCLC, this is early-stage (stage A) HCC with impaired liver function and portal hypertension. Resection is reserved for patients with preserved liver function (Child-Pugh A) and no portal hypertension; thus option B is inappropriate. For early HCC within Milan criteria and decompensated/portal hypertensive cirrhosis, liver transplantation is the recommended curative therapy, matching option A. Ablation (C) is generally for small tumors in patients who are not transplant candidates or as bridge/downstaging, so it is inferior here. TACE (D) is for intermediate (BCLC B) multinodular disease, not single early tumor. Sorafenib (E) is systemic therapy for advanced HCC (BCLC C). The explanation correctly aligns with widely accepted BCLC guidance.\nMain medical accuracy issue(s): None significant; content is guideline-consistent.\nMinimal fix: Optionally, explicitly state “meets Milan criteria” or “BCLC stage A” in the stem to make the staging assumption explicit, though not strictly necessary.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128", "question_id": "20251218T014545383Z_claude-opus-4-5-20251101_seed128-020", "question": "A 62-year-old woman with type 2 diabetes presents with a 2-day history of severe right eye pain, redness, and decreased vision. She reports seeing halos around lights. Visual acuity is counting fingers at 2 feet OD and 20/30 OS. Examination reveals conjunctival injection, corneal edema with microcystic changes, a mid-dilated non-reactive pupil, and shallow anterior chamber OD. Intraocular pressure is 58 mmHg OD and 16 mmHg OS. Gonioscopy of the left eye shows narrow angles with appositional closure in the superior quadrant. After initial medical therapy with topical timolol, brimonidine, pilocarpine, and intravenous acetazolamide, IOP decreases to 32 mmHg at 2 hours. Corneal edema persists. Which of the following is the most appropriate definitive treatment?", "options": ["Laser peripheral iridotomy of the right eye only", "Laser peripheral iridotomy of both eyes", "Trabeculectomy of the right eye", "Phacoemulsification with intraocular lens implantation of the right eye", "Argon laser trabeculoplasty of the right eye"], "answer": "B", "answer_index": 1, "explanation": "This patient has acute primary angle-closure glaucoma (APACG). Laser peripheral iridotomy (LPI) is the definitive treatment as it creates an alternative pathway for aqueous flow, relieving pupillary block. Critically, LPI must be performed on BOTH eyes because angle-closure is a bilateral anatomical predisposition-the fellow eye has a 40-80% risk of developing acute angle closure if left untreated, as evidenced by the narrow angles with appositional closure seen on gonioscopy OS. Trabeculectomy is reserved for cases with persistent IOP elevation after LPI. Phacoemulsification may be considered later but is not first-line. Argon laser trabeculoplasty is contraindicated in angle closure.", "generator_model": "claude-opus-4-5-20251101", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Ophthalmology", "judge_model": "gpt-5.1-2025-11-13", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V\\nVerdict on keyed answer: Correct best\\n\\nKey stem clues: Older woman with hyperacute onset of severe unilateral eye pain, redness, halos, markedly decreased vision, corneal edema, mid-dilated fixed pupil, shallow anterior chamber, and very high IOP (58 mmHg) all indicate acute primary angle-closure glaucoma. Gonioscopy of the fellow eye shows narrow angles with appositional closure, confirming a bilateral anatomic predisposition. IOP is partially lowered with appropriate acute medical therapy, but corneal edema persists, so a definitive anatomic treatment is required.\\n\\nLaser peripheral iridotomy (LPI) is the standard definitive treatment for pupillary-block angle closure, and guidelines recommend prophylactic LPI to the fellow eye because of high contralateral risk and narrow angles on gonioscopy. Thus, option B (bilateral LPI) is superior to unilateral LPI (A). Trabeculectomy (C) is reserved for failure of LPI/medical therapy. Phacoemulsification (D) can be considered in chronic/recurrent disease or with cataract but is not first-line in this acute setting. Argon laser trabeculoplasty (E) is inappropriate in angle-closure.\\n\\nMain medical issues: None; teaching point and rationale are accurate and current.\\n\\nMinimal fix: Add an explicit statement that corneal clarity becomes adequate for LPI to emphasize timing, though implied by partial IOP reduction.\\n\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V\nVerdict on keyed answer: Correct best\n\nKey stem clues: Older woman with hyperacute onset of severe unilateral eye pain, redness, halos, markedly decreased vision, corneal edema, mid-dilated fixed pupil, shallow anterior chamber, and very high IOP (58 mmHg) all indicate acute primary angle-closure glaucoma. Gonioscopy of the fellow eye shows narrow angles with appositional closure, confirming a bilateral anatomic predisposition. IOP is partially lowered with appropriate acute medical therapy, but corneal edema persists, so a definitive anatomic treatment is required.\n\nLaser peripheral iridotomy (LPI) is the standard definitive treatment for pupillary-block angle closure, and guidelines recommend prophylactic LPI to the fellow eye because of high contralateral risk and narrow angles on gonioscopy. Thus, option B (bilateral LPI) is superior to unilateral LPI (A). Trabeculectomy (C) is reserved for failure of LPI/medical therapy. Phacoemulsification (D) can be considered in chronic/recurrent disease or with cataract but is not first-line in this acute setting. Argon laser trabeculoplasty (E) is inappropriate in angle-closure.\n\nMain medical issues: None; teaching point and rationale are accurate and current.\n\nMinimal fix: Add an explicit statement that corneal clarity becomes adequate for LPI to emphasize timing, though implied by partial IOP reduction.\n", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]